Current Market Information

Last Trade Price (LTP) 297.20 Last Trade Date 08 February, 2023 Change 1.26 % Open Price 293.50 Day's Range 297.20 - 297.20     Total Trade 2 Total Volume 17 Close Price 297.20 Yesterday Close Price 293.50 Market Capital in BDT (mn) 68653.200

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Nurun Nahar Karim 01913397900 nkarim@beaconpharma.com.bd MD Mr. Mohammad Ebadul Karim 01713240344 ebadul@beaconpharma.com.bd CFO Mr. Md. Abdul Haque Sarder, FCS FCA 01713156222 sarder@beacongroup.com.bd Company Secretary Mr. Khalilur Rahman FCS 01730025982 khalilur-acc@beaconpharma.com.bd Office Address Beacon Business Centre, 9/B/2, Toyenbee Circular Road, Motijheel C/A, Dhaka-1223 Phone : 02-57165371-76 Fax : 02-57165379 Email : beacon@beaconpharma.com.bd Website : http://www.beaconpharma.com.bd Factory Address Beacon Pharmaceuticals Limited,Khathali, Bhaluka, Mymemsingh

Basic Information

Authorized Capital in BDT* (mn) 3,000.00 Paid-up Capital in BDT* (mn) 2,310.00 Face Value 10 Paid up Share 231000000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 2010 Debut Trade Date 12 August, 2010 Type of Instrument     52 Week's Range 218.60 - 378.40 Year End 202206 Reserve / Surplus(mn) 3635.5 Remarks Tk 1,231,058,381 Revaluation Surplus has been added to Reserve & Surplus. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Dec, 2022 30.003 0 36.297 0 33.7 As on 30-Nov, 2022 30.003 0 36.23 0 33.767 As on 31-Oct, 2022 30.003 0 36.09 0 33.907 As on 30-Jun, 2022 (year ended) 30.003 0 34.046 0 35.951     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Dec 05, 2022 A1 ST-3 Stable Nov 30, 2023 Credit Rating Agency of Bangladesh Ltd. (CRAB)         Half Year End (HY) Information  202112 HY Net Turnover(mn)  4342.72 HY Net Profit after tax(mn)  598.30 HY EPS  2.59  AGM Information   AGM Date  27 December, 2022 Record Date  17 November, 2022 Dividend(%)  16.00(cash) Bonus Issue  5% 2011

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2022	4.05	0	0	0	25.73	0	935.04	0	16%C	0.62
2021	3.74	0	0	0	23.18	0	863.17	0	15%C	1.21
2020	1.65	0	0	0	20.04	0	380.69	0	6%C	0.99
2019	0.51	0	0	0	12.9	0	117.7	0	5%C	2.49
2018	0.55	0	0	0	12.99	0	126.1	0	6%C	3.37

Financial Statements
Quarterly Financial Statement	https://www.beaconpharma.com.bd/financial-statements/
Price Sensitive Information	https://www.beaconpharma.com.bd/price-sensitive-informations/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To